Online health and wellness company Hims & Hers is evolving its direct-to-consumer telehealth and prescription drug platform, with plans to add blood-sample collection diagnostics. The company also ...

The renowned health and wellness platform, Hims & Hers Health, Inc.’s HIMS, business model links virtual consultations directly to prescription access and home delivery. Customers meet with ...

Nov 17 (Reuters) - Hims & Hers Health (HIMS.N), opens new tab has appointed Deb Autor as its first chief policy officer to lead public policy and government functions, the telehealth firm said on ...

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Deb Autor as the company’s first Chief Policy Officer. In this new role, Autor will ...

Hims & Hers—the virtual care platform with about 2.5 million subscribers—will now offer laboratory testing through Quest Diagnostics. Customers will have access to more than 120 biomarker tests across ...

Hims & Hers Health (HIMS 2.73%) demonstrated once again why it's one of the most interesting growth stocks outside of the tech sector when it reported strong Q3 results. While the stock has been ...

Hims & Hers Health (HIMS) traded ~6% higher on Tuesday after the telehealth platform, with its Q3 2025 results, said it is in "active discussions" with Novo Nordisk (NVO) to sell the Danish ...

Hims & Hers Health Inc. rose after the telehealth company said it was in talks with Novo Nordisk A/S to sell its forthcoming obesity pill on the telehealth site. Hims does not yet have an agreement ...

CEO says company accelerating toward 2030 $6.5 billion revenue goal Talks with Novo to offer Wegovy through Hims' platform remain ongoing Revenue beat driven by core offerings - analyst Nov 3 (Reuters ...

The telehealth revolution that transformed how millions of Americans access healthcare is facing a reality check, as one of the industry’s most prominent companies grapples with the challenge of ...